Target intelligence / Profile preview

Ribosomal protein L26 pseudogene 37 (RPL26P37)

Target
RPL26P37
Molecular classification
Pseudogene
01

Overview

Ribosomal protein L26 pseudogene 37 (*RPL26P37*) is a **pseudogene** related to the gene encoding ribosomal protein L26, which is a component of the large subunit (60S) of the ribosome. Pseudogenes are genetic sequences that resemble functional genes but typically contain mutations or defects (such as stop codons or frameshifts) that prevent them from producing functional proteins. RPL26P37 does not encode a functional protein and has no known biological or disease role. It has been identified as one of many processed ribosomal protein pseudogenes in the human genome, originating via retrotransposition. Unlike true molecular targets such as receptors, enzymes, or transporters, ribosomal protein pseudogenes like RPL26P37 are not considered drug targets and have no therapeutic relevance[2][3][4]. \n\n**Note:** This entry is a pseudogene, not a functional protein or therapeutic target. If a test, screen, or drug refers to "RPL26P37" as a molecular target, this is incorrect and likely due to confusion with the functional ribosomal protein L26 gene.

Other names
RPL26_17_1822RPL26P37

Beyond the preview

Go deeper on Ribosomal protein L26 pseudogene 37 (RPL26P37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L26 pseudogene 37 (RPL26P37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call